Technology News and Research

RSS

BIOTRONIK announces FDA IDE approval and first patient enrollment for TOCCASTAR clinical trial

BIOTRONIK SE Co. & KG highlights two key milestones toward receiving premarket approval (PMA) of the TactiCath, a novel technology for treating atrial fibrillation (AF): FDA IDE (investigational device exemption) approval and the first patient enrollment of the TOCCASTAR (TactiCath Contact Force Ablation Catheter Study for Atrial Fibrillation) clinical trial.

14 Jan 2011

Centice launches integration and solutions platform for Computational Raman Spectroscopy application

Centice Corporation, a pioneer in chemical verification and identification using Raman Spectroscopy and computational sensor technology, announced today the availability of an integration and solutions platform for the application of Computational Raman Spectroscopy to satisfy technology needs in process manufacturing, healthcare, public safety and materials science.

14 Jan 2011

T.A. Sciences receives US patent for TA-65 to tackle aging process

Telomerase Activation Sciences, today announced the issuance of U.S. Patent No. 7,846,904 to the Geron Corporation. The patent covers the use of certain compounds to upregulate telomerase expression in cells.

14 Jan 2011

CJSM highlights emerging issues in sport medicine

Should electrocardiograms be included in cardiovascular screening of athletes? What's the current status of research into long-term effects of concussions? These and other hot topics are the focus of the January Clinical Journal of Sport Medicine, a special issue on "Emerging Issues in Sport Medicine."

14 Jan 2011

Metabolic profiling of tissue samples may transform the way surgeons make decisions

Metabolic profiling of tissue samples could transform the way surgeons make decisions in the operating theatre, say researchers at a new laboratory being launched today. Scientists at Imperial College London, in partnership with clinicians at Imperial College Healthcare NHS Trust, have installed a high resolution solid state nuclear magnetic resonance (NMR) spectrometer in St Mary's Hospital.

13 Jan 2011

Abuse of legal substances

The Internet, smart phones and teens' endless search for self-acceptance in their technology connected yet isolated world is driving a revival of substance abuse of salvia, an herb from flower seeds that induces psychedelic effects but is not detectable with usual drug tests, and synthetic cannabis, a psychoactive herbal and chemical concoction, also undetectable, popularly known around high schools as "spice".

13 Jan 2011

PPPI-III conference to focus on fundamental research and industrial application of particulate processing

Over 80% of all pharmaceutical products are in the solid dosage form. Particulate processes therefore abound in the pharmaceutical industry. These include crystallization; drying, granulation, and coating; tablet compaction; fine powder transport, mixing, and blending. These and other particulate processes are used for the large-scale manufacture of tablets and capsules as well as dry powder inhalants for public consumption.

13 Jan 2011

Apollo Munich Health Insurance honored with Celent Model Insurer Asia 2011 award

Apollo Munich Health Insurance Co. Ltd. (AMHI), was felicitated with the Celent Model Insurer Asia 2011 award in the Policy Administration System (PAS) category. The award recognizes excellence in technology best practices at insurers in Asia, in various categories.

13 Jan 2011

NEJM releases findings about behavioral impact of personal genetic testing

Navigenics, a leading personal genomics company, announced today that The New England Journal of Medicine has published findings from the Scripps Genomic Health Initiative, a research study sponsored by Scripps Translational Science Institute to assess the behavioral impact of personal genetic testing.

13 Jan 2011

Robot-assisted surgery improves outcomes in uterine, endometrial, and cervical cancer patients

Robot-assisted surgery dramatically improves outcomes in patients with uterine, endometrial, and cervical cancer, said researchers at the Jewish General Hospital's Lady Davis Institute for Medical Research in Montreal. Moreover, because of fewer post-operative complications and shorter hospital stays, robotic procedures also cost less.

13 Jan 2011

DNAVision purchases 4 of Life Technologies' NGS platforms

DNAVision, one of European leading genetic analysis service providers, is pleased to announce the purchase of four next-generation sequencing platforms from Life Technologies, including two latest 5500xl SOLiD™ Systems.

13 Jan 2011

NIH awards VistaGen and NuPotential $500,000 grant to advance iPS stem cell technology

VistaGen Therapeutics, Inc. and NuPotential, Inc. today announced that the National Heart, Lung and Blood Institute of the U.S. National Institutes of Health (NIH) has awarded to the companies a grant of approximately $500,000 to accelerate development of novel and safer approaches to generate patient-specific induced pluripotent stem (iPS) cells for regenerative medicine, drug discovery and drug rescue.

13 Jan 2011

Marshfield Clinic, Physicians Practice join forces to enhance patient care

Physicians Practice and Marshfield Clinic have joined forces to help provide area physicians, other providers, and their staff more time to devote to patient care. This new partnership is a unique program designed to help doctors in Wisconsin and the Upper Peninsula of Michigan better handle the cumbersome and time-consuming issues of managing a busy practice.

13 Jan 2011

The neuroscience of musical chills

Scientists have found that the pleasurable experience of listening to music releases dopamine, a neurotransmitter in the brain important for more tangible pleasures associated with rewards such as food, drugs and sex. The new study from The Montreal Neurological Institute and Hospital - The Neuro at McGill University also reveals that even the anticipation of pleasurable music induces dopamine release [as is the case with food, drug, and sex cues].

13 Jan 2011

Medical breakthrough: Surgeons use stem cells from patient's fat for cosmetic procedure

We've all heard stories about medical breakthroughs involving stem cells in recent years. But stem cells and cosmetic surgery? "We've learned that your own fat is a great source for stem cells," says Dr. Mark Berman, MD, President of the American Academy of Cosmetic Surgery. "With our current technology, we can harvest fat and actually separate the stem cells."

13 Jan 2011

TKM-PLK1 drug may offer hope for patients with advanced solid tumor cancers

A new investigational drug designed to stop cancer cells from reproducing may offer hope for patients with advanced solid tumor cancers. Clinical trials of TKM-PLK1 for qualified patients are now open at the Virginia G. Piper Cancer Center at Scottsdale Healthcare.

13 Jan 2011

UCLA imaging system could help reveal 'miscommunications' in autism, schizophrenia

Some disorders of the brain are obvious - the massive death of brain cells after a stroke, the explosion in the growth of cells that marks a tumor. Other disorders, such as autism, schizophrenia and mental retardation show no physical signs of damage and are believed to be caused by problems in how brain cells communicate with one another.

13 Jan 2011

Exposure to 'thirdhand smoke' poses additional health risks

Scientists are reporting that so-called "thirdhand smoke" - the invisible remains of cigarette smoke that deposits on carpeting, clothing, furniture and other surfaces - may be even more of a health hazard than previously believed. The study, published in ACS' journal, Environmental Science & Technology, extends the known health risks of tobacco among people who do not smoke but encounter the smoke exhaled by smokers or released by smoldering cigarette butts.

13 Jan 2011

FDA accepts to review Fibrocell Science's azficel-T drug

Fibrocell Science, a biotechnology company focused on the development of autologous cell therapies for aesthetic, medical and scientific applications, announced today that the U.S. Food & Drug Administration has accepted for review the Company's complete response submission for azficel-T, proposed brand name laViv, for the treatment of moderate to severe nasolabial folds and wrinkles.

12 Jan 2011

ZOLL announces successful conclusion of Circulation Improving Resuscitation Care trial

ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced today the successful conclusion of the ZOLL-sponsored CIRC trial. The trial's Data Safety Monitoring Board (DSMB) closed enrollment when an analysis of the data showed the load-distributing band (AutoPulse® Non-invasive Cardiac Support Pump) to be equivalent to manual chest compressions.

12 Jan 2011

Technology News and Research

BIOTRONIK announces FDA IDE approval and first patient enrollment for TOCCASTAR clinical trial

Centice launches integration and solutions platform for Computational Raman Spectroscopy application

T.A. Sciences receives US patent for TA-65 to tackle aging process

CJSM highlights emerging issues in sport medicine

Metabolic profiling of tissue samples may transform the way surgeons make decisions

Abuse of legal substances

PPPI-III conference to focus on fundamental research and industrial application of particulate processing

Apollo Munich Health Insurance honored with Celent Model Insurer Asia 2011 award

NEJM releases findings about behavioral impact of personal genetic testing

Robot-assisted surgery improves outcomes in uterine, endometrial, and cervical cancer patients

DNAVision purchases 4 of Life Technologies' NGS platforms

NIH awards VistaGen and NuPotential $500,000 grant to advance iPS stem cell technology

Marshfield Clinic, Physicians Practice join forces to enhance patient care

The neuroscience of musical chills

Medical breakthrough: Surgeons use stem cells from patient's fat for cosmetic procedure

TKM-PLK1 drug may offer hope for patients with advanced solid tumor cancers

UCLA imaging system could help reveal 'miscommunications' in autism, schizophrenia

Exposure to 'thirdhand smoke' poses additional health risks

FDA accepts to review Fibrocell Science's azficel-T drug

ZOLL announces successful conclusion of Circulation Improving Resuscitation Care trial

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News